News | Radiation Therapy | February 03, 2016

Radioactive Medicine Markets Poised for Double-digit Growth

Nuclear medicine, proton therapy and brachytherapy expected to grow more than twice as fast as total global health expenditures to 2030

MEDraysintell, nuclear medicine, proton therapy, brachytherapy, global markets, 2030

February 3, 2016 — The nuclear medicine, proton therapy and brachytherapy markets represent less than 0.1 percent of global health expenditures but are expected to grow more than twice as fast, according to a new report from MEDraysintell.

Global health expenditures reached some $7.4 billion in 2014 and should grow by 3-4 percent per year to 2030. The nuclear medicine, proton therapy and brachytherapy markets reached about $5.8 billion in 2014 and are expected to grow by 10-11 percent annually to 2030. There is an increasing interest from investors and industry as new technologies and products are being marketed or under development.

The global nuclear medicine market is expected to reach $24 billion by 2030, showing an annual average growth of 11 percent, with radiotherapeutics being key drivers of this growth. The number of operational medical cyclotrons is also expected to grow with the emergence of the Asian and South American markets and the need of tools for new proprietary tracers.

The global proton therapy market saw record sales orders at just over $1 billion in 2015, more than twice as much as in 2014.

The global market for brachytherapy is expected to grow by 8 percent a year to 2030, mainly driven by microspheres and electronic brachytherapy and with the low-dose rate (LDR) brachytherapy seeds market mainly growing in emerging regions.

For more information: www.medraysintell.com

Related Content

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane